Claudia Mazzà, Lisa Alcock, Kamiar Aminian, Clemens Becker, Stefano Bertuletti, Tecla Bonci, Philip Brown, Marina Brozgol, Ellen Buckley, Anne-Elie Carsin, Marco Caruso, Brian Caulfield, Andrea Cereatti, Lorenzo Chiari, Nikolaos Chynkiamis, Fabio Ciravegna, Silvia Del Din, Björn Eskofier, Jordi Evers, Judith Garcia Aymerich, Eran Gazit, Clint Hansen, Jeffrey M Hausdorff, Jorunn L Helbostad, Hugo Hiden, Emily Hume, Anisoara Paraschiv-Ionescu, Neil Ireson, Alison Keogh, Cameron Kirk, Felix Kluge, Sarah Koch, Arne Küderle, Vitaveska Lanfranchi, Walter Maetzler, M Encarna Micó-Amigo, Arne Mueller, Isabel Neatrour, Martijn Niessen, Luca Palmerini, Lucas Pluimgraaff, Luca Reggi, Francesca Salis, Lars Schwickert, Kirsty Scott, Basil Sharrack, Henrik Sillen, David Singleton, Abolfazi Soltani, Kristin Taraldsen, Martin Ullrich, Linda Van Gelder, Beatrix Vereijken, Ioannis Vogiatzis, Elke Warmerdam, Alison Yarnall, Lynn Rochester
INTRODUCTION: Existing mobility endpoints based on functional performance, physical assessments and patient self-reporting are often affected by lack of sensitivity, limiting their utility in clinical practice. Wearable devices including inertial measurement units (IMUs) can overcome these limitations by quantifying digital mobility outcomes (DMOs) both during supervised structured assessments and in real-world conditions. The validity of IMU-based methods in the real-world, however, is still limited in patient populations...
December 2, 2021: BMJ Open